FHJTX
Price
$38.02
Change
-$0.54 (-1.40%)
Updated
Sep 20 closing price
VEUPX
Price
$166.69
Change
-$2.82 (-1.66%)
Updated
Sep 20 closing price
Ad is loading...

FHJTX vs VEUPX

Header iconFHJTX vs VEUPX Comparison
Open Charts FHJTX vs VEUPXBanner chart's image
Fidelity Advisor Europe C
Price$38.02
Change-$0.54 (-1.40%)
VolumeN/A
CapitalizationN/A
Vanguard European Stock Instl Plus
Price$166.69
Change-$2.82 (-1.66%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FHJTX vs VEUPX Comparison Chart
Loading...
VS
FHJTX vs. VEUPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHJTX is a Buy and VEUPX is a Buy.

FUNDAMENTALS
Fundamentals
VEUPX has more cash in the bank: 26.3B vs. FHJTX (636M). VEUPX pays higher dividends than FHJTX: VEUPX (3.26) vs FHJTX (0.21). FHJTX was incepted earlier than VEUPX: FHJTX (11 years) vs VEUPX (10 years). FHJTX is a more actively managed with annual turnover of: 37.00 vs. VEUPX (4.00). FHJTX has a lower initial minimum investment than VEUPX: FHJTX (0) vs VEUPX (100000000). FHJTX annual gain was more profitable for investors over the last year : 21.87 vs. VEUPX (19.16). VEUPX return over 5 years is better than : 30.28 vs. FHJTX (10.08).
FHJTXVEUPXFHJTX / VEUPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years10 years-
Gain YTD11.3658.773130%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets636M26.3B2%
Annual Yield % from dividends0.213.266%
Returns for 1 year21.8719.16114%
Returns for 3 years-14.404.95-291%
Returns for 5 years10.0830.2833%
Returns for 10 years2.9829.5210%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KWE0.170.02
+12.95%
KWESST Micro Systems
ADSE10.920.62
+6.02%
Ads-Tec Energy PLC
ROIV11.970.05
+0.42%
Roivant Sciences Ltd
RSSS2.80N/A
N/A
Research Solutions
AMPH49.18-0.91
-1.82%
Amphastar Pharmaceuticals